Organophosphorus compounds
![eMolecules ChemScene / 6-Azabicyclo[3.2.0]heptan-7-one / 100mg / 569144765 / CS-0063926 / 0.000 / 22031-52-3 / MFCD01863277 / 111.144 / C6H9NO](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502452107.PNG-250.jpg)
eMolecules ChemScene / 6-Azabicyclo[3.2.0]heptan-7-one / 100mg / 569144765 / CS-0063926 / 0.000 / 22031-52-3 / MFCD01863277 / 111.144 / C6H9NO
ChemScene / 6-Azabicyclo[3.2.0]heptan-7-one / 100mg / 569144765 / CS-0063926 / 0.000 / 22031-52-3 / MFCD01863277 / 111.144 / C6H9NO
Strem, An Ascensus Company CAS# 13716-10-4. 25g. Di-t-butylchlorophosphine, min. 98%. MFCD00008815
CAS# 13716-10-4. 25g. Di-t-butylchlorophosphine, min. 98%. MFCD00008815. Molecular Weight: 180.66. Molecular Formula: [(CH3)3C]2PCl. Color/form: colorless to light yellow liq. Strem# 15-1000. http://www.strem.com/catalog/v/15-1000/
Medchemexpress LLC LEP(116-130)(mouse) | 258276-95-8 | 99.2% | 1560.73 | 5 MG
LEP(116-130)(mouse) is a synthetic leptin peptide fragment intended for research use only. It has been shown to reduce body weight gain and blood glucose levels in vivo.
- Unable to inhibit AP-OB binding in vitro
- Reduces rate of body weight gain in vivo despite increased food intake
- Significantly reduces blood glucose levels by approximately 100 mg/dL in vivo
- No effect on the ability to thermoregulate in wild-type mice
![eMolecules Pharmablock / tert-butyl (2S4S)-24-bis(hydroxymethyl)azetidine-1-carboxylate / 25mg / 761745581 / PBUB830 / 0.000 / 1016233-28-5 / [null] / 217.265 / C10H19NO4](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502456325.PNG-250.jpg)
eMolecules Pharmablock / tert-butyl (2S4S)-24-bis(hydroxymethyl)azetidine-1-carboxylate / 25mg / 761745581 / PBUB830 / 0.000 / 1016233-28-5 / [null] / 217.265 / C10H19NO4
Pharmablock / tert-butyl (2S4S)-24-bis(hydroxymethyl)azetidine-1-carboxylate / 25mg / 761745581 / PBUB830 / 0.000 / 1016233-28-5 / [null] / 217.265 / C10H19NO4
Medchemexpress LLC YKL-1-116 5mg | 1957202-71-9 | 606.72 | C34H38N8O3 | 5 MG
YKL-1-116 is a selective, covalent inhibitor of cyclin-dependent kinase 7 (CDK7) used in laboratory research to probe CDK7-dependent cell cycle and transcriptional processes. It is more potent than related inhibitors against CDK7 and shows limited activity against CDK9, CDK12, and CDK13. Supplied as a small, high-purity solid for research use only (not for human consumption).
- Selective covalent inhibitor of CDK7.
- Higher potency against CDK7 compared with related compounds.
- Minimal activity against CDK9, CDK12, and CDK13.
- High reported purity (~98.7%).
- Provided as a small solid quantity suitable for in vitro research.
- Molecular weight 606.72 and formula C34H38N8O3.
Medchemexpress LLC EMU-116 | 2241724-59-2 | 98.5% | 405.58 | 1 ML
EMU-116 is an orally active CXCR4 antagonist. EMU-116 can be used in the study of cancer. For research use only. We do not sell to patients.
- Orally active CXCR4 antagonist
- Can be used in the study of cancer
Medchemexpress LLC Lep(116-130)(mouse) | 258276-95-8 | 99.2% | 1560.73 | 10 MG
LEP(116-130)(mouse) is a synthetic leptin peptide fragment intended for research use only. In vivo studies have shown that it can lead to a reduced rate of body weight gain, despite increased food intake, and significantly lowers blood glucose levels.
- Synthetic leptin peptide fragment
- Unable to inhibit AP-OB binding in vitro
- Reduces body weight gain
- Increases food intake
- Significantly reduces blood glucose levels
- No effect on thermoregulation in C57BLKS/J-m mice
Pfaltz & Bauer Tetrabutylphosphonium bromide 25G | 3115-68-2
Tetrabutylphosphonium bromide 25G | 3115-68-2
Medchemexpress LLC Prostatic Acid Phosphatase Antibody (YA5619) | 68 kDa | 100 UL
Prostatic Acid Phosphatase Antibody (YA5619) is a Mouse-derived, non-conjugated IgG2b monoclonal antibody targeting Prostatic Acid Phosphatase. It is supplied in PBS, 50% glycerol, 0.05% Proclin 300, 0.05% BSA. PAP is a non-specific tyrosine phosphatase that dephosphorylates various substrates under acidic conditions, and acts as a tumor suppressor in prostate cancer by dephosphorylating ERBB2 and deactivating MAPK-mediated signaling. It also possesses ecto-5'-nucleotidase activity in dorsal root ganglion (DRG) neurons, generating adenosine from AMP to suppress pain.
- Mouse-derived IgG2b monoclonal antibody
- Targets prostatic acid phosphatase
- Dephosphorylates various substrates under acidic conditions
- Acts as a tumor suppressor in prostate cancer
- Exhibits ecto-5'-nucleotidase activity
- Applications include IHC-P, WB, ICC/IF, and ELISA
- Stored at -20°C for 1 year; avoid repeated freeze/thaw cycles